R1 RCM Inc. - RCM Real Price to Acquire Entire Company

R1 RCM - graphic logo of issuer RCM

The market trend for R1 RCM Inc. (RCM), visualized in monetary terms, demonstrates a business valuation of , supported by high barriers to entry due to software implementation complexity and strict HIPAA compliance. Growth is driven by the large-scale digitalization of financial flows within hospitals, while rumors of a private equity buyout are already priced in. The company's stability relies on the critical role of its IT infrastructure in securing profitability for medical centers.

RCM R1 RCM Real Price to Acquire Entire Company (07/04/2022 - 10/28/2026)

R1 RCM - analytical breakdowns and key metrics (RCM)

- price and consensus price forecast:
Stock Quotes R1 RCM, Inc.|RCM - Price Target Chart
- market capitalization data:
Market Valuation R1 RCM|RCM - Enterprise Value
- book capitalization data:
Net Assets per Share R1 RCM|RCM - Company Net Assets|Market Cap to Book Value Multiple r1rcm.com|RCM - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio R1 RCM Inc.|RCM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio R1 RCM, Inc.|RCM - Company Aggregate Debts|Debts to Book Value R1 RCM|RCM - Company Long-Term Debts|Company Short-Term Indebtedness R1 RCM
Fundamental valuation:RCM (R1 RCM Inc.)
Manufactured products of R1 RCM Inc

To objectively assess the operational efficiency of R1 RCM Inc. (RCM), investors must consider the total business value beyond simple market capitalization. The current enterprise value indicator at aggregates the market value of equity and net debt, allowing for an assessment of the actual acquisition price of the company while accounting for IT integration risks and the complexities of health insurance dependency.

Competitor analysis

Veeva Systems - Real Price to Acquire Entire Company|DOCS: Total Company Value|HQY - Real Price to Acquire Entire Company|Waystar Holding Corp. - Enterprise Value|Company Buyout Price corvel.com|Privia Health (PRVA) - Real Price to Acquire Entire Company|Aggregate Business Value Huron Consulting Group Inc. (HURN)|Certara Corp (CERT) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash OMCL (Omnicell Health)|GoodRx Holdings, Inc. - Total Company Value|Real Price to Acquire Entire Company schrodinger.com SDGR|PHR (Phreesia) - Enterprise Value|OMDA - Total Enterprise Value|Enterprise Value Evolent|HSTM (HealthStream Learning) - Business Value|DH - Total Company Value|Value Adjusted for Debt and Cash consensus.com|Enterprise Value AGL (agilon health)|ABSI (Absci Corp) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash SoYoung SY|Total Company Value NRC|Spok Holdings, Inc. - Value Adjusted for Debt and Cash|optimizerx.com (OPRX) - Enterprise Value|TruBridge (TBRG) - Real Price to Acquire Entire Company|Total Company Value Simulations Plus Inc|Real Price to Acquire Entire Company SOPH|HCAT: Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash CCLD|Enterprise Value Research Solutions Inc.|Company Buyout Price DLH Holdings DLHC|ONMD: Total Company Value|Scienture Holdings Inc. - Business Value|Healthcare Triangle Corporation (HCTI) - Enterprise Value|ISPC (ispecimen.com) - Real Price to Acquire Entire Company|BFRG - Real Price to Acquire Entire Company|Company Buyout Price SCWorx|MSPR: Total Company Value|Value Adjusted for Debt and Cash ICCT|Enterprise Value TRxADE Health Corp MEDS|Real Price to Acquire Entire Company Orgenesis Inc. ORGS|SHCR - Total Company Value|Streamline Health - Real Price to Acquire Entire Company|Enterprise Value Syra Health Corp SYRA|AMEH (apollomed.net) - Company Buyout Price|MODN: Real Price to Acquire Entire Company|Aggregate Business Value NXGN